Modelling suggests that the Lassa virus could infect millions in a decade, but vaccines under development could sharply ...
Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United ...
Nigeria: Ten Years After Ebola - Learnings for Lassa Fever, 'Lassa-X' and Pandemic Preparedness Lead
Blog - In global health, past epidemics are important learning experiences that shape our responses to future health emergencies. The 2014 Ebola epidemic in West Africa serves as a stark reminder of ...
Researchers developed the LASSARAB vaccine, using a deactivated rabies virus to protect against Lassa fever. In preclinical ...
A promising Lassa fever vaccine shows potential to prevent severe disease and death in animals.
The vaccine, named LASSARAB, uses a deactivated rabies virus platform to deliver antigens to protect against the Lassa fever virus. Lassa fever is a severe hemorrhagic disease that is endemic to ...
Lassa fever is a deadly viral hemorrhagic illness that lowers the platelet count in the blood and its ability to clot, ...
Nigeria is at the forefront of the Lassa fever crisis in West Africa, with a recent study revealing that the country bears over 50% of the West Africa’s cases of 2.7 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback